These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

556 related items for PubMed ID: 22884163

  • 1. Prognostic significance of total lesion glycolysis in patients with advanced non-small cell lung cancer receiving chemotherapy.
    Zaizen Y, Azuma K, Kurata S, Sadashima E, Hattori S, Sasada T, Imamura Y, Kaida H, Kawahara A, Kinoshita T, Ishibashi M, Hoshino T.
    Eur J Radiol; 2012 Dec; 81(12):4179-84. PubMed ID: 22884163
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Baseline SUVmax at PET-CT in stage IIIA non-small-cell lung cancer patients undergoing surgery after neoadjuvant therapy: prognostic implication focused on histopathologic subtypes.
    Lee HY, Lee KS, Park J, Han J, Kim BT, Kwon OJ, Ahn YC, Ahn MJ, Park K, Kim J, Shim YM.
    Acad Radiol; 2012 Apr; 19(4):440-5. PubMed ID: 22265854
    [Abstract] [Full Text] [Related]

  • 5. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
    Heusch P, Buchbender C, Köhler J, Nensa F, Beiderwellen K, Kühl H, Lanzman RS, Wittsack HJ, Gomez B, Gauler T, Schuler M, Forsting M, Bockisch A, Antoch G, Heusner TA.
    Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Fluorine 18 fluorodeoxyglucose PET/CT volume-based indices in locally advanced non-small cell lung cancer: prediction of residual viable tumor after induction chemotherapy.
    Soussan M, Cyrta J, Pouliquen C, Chouahnia K, Orlhac F, Martinod E, Eder V, Morère JF, Buvat I.
    Radiology; 2014 Sep; 272(3):875-84. PubMed ID: 24761836
    [Abstract] [Full Text] [Related]

  • 8. Prognostic value of total lesion glycolysis by 18F-FDG PET/CT in surgically resected stage IA non-small cell lung cancer.
    Park SY, Cho A, Yu WS, Lee CY, Lee JG, Kim DJ, Chung KY.
    J Nucl Med; 2015 Jan; 56(1):45-9. PubMed ID: 25525185
    [Abstract] [Full Text] [Related]

  • 9. FDG-PET as a potential tool for selecting patients with advanced non-small cell lung cancer who may be spared maintenance therapy after first-line chemotherapy.
    Yoon DH, Baek S, Choi CM, Lee DH, Suh C, Ryu JS, Moon DH, Lee JS, Kim SW.
    Clin Cancer Res; 2011 Aug 01; 17(15):5093-100. PubMed ID: 21673067
    [Abstract] [Full Text] [Related]

  • 10. Relationship between primary lesion metabolic parameters and clinical stage in lung cancer.
    Sahiner I, Atasever T, Akdemir UO, Ozturk C, Memis L.
    Rev Esp Med Nucl Imagen Mol; 2013 Aug 01; 32(6):357-63. PubMed ID: 23747221
    [Abstract] [Full Text] [Related]

  • 11. Prognostic value of SUVmax and metabolic tumor volume on 18F-FDG PET/CT in early stage non-small cell lung cancer patients without LN metastasis.
    Yoo IeR, Chung SK, Park HL, Choi WH, Kim YK, Lee KY, Wang YP.
    Biomed Mater Eng; 2014 Aug 01; 24(6):3091-103. PubMed ID: 25227018
    [Abstract] [Full Text] [Related]

  • 12. Continued pemetrexed and platin-based chemotherapy in patients with malignant pleural mesothelioma (MPM): value of 18F-FDG-PET/CT.
    Schaefer NG, Veit-Haibach P, Soyka JD, Steinert HC, Stahel RA.
    Eur J Radiol; 2012 Jan 01; 81(1):e19-25. PubMed ID: 21129871
    [Abstract] [Full Text] [Related]

  • 13. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in patients undergoing stereotactic body radiation therapy for stage I non-small-cell lung cancer.
    Vu CC, Matthews R, Kim B, Franceschi D, Bilfinger TV, Moore WH.
    Nucl Med Commun; 2013 Oct 01; 34(10):959-63. PubMed ID: 23921784
    [Abstract] [Full Text] [Related]

  • 14. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
    Hyun SH, Choi JY, Kim K, Kim J, Shim YM, Um SW, Kim H, Lee KH, Kim BT.
    Ann Surg; 2013 Feb 01; 257(2):364-70. PubMed ID: 22968069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG, Moustafa HM, Khalil HF, Liao CT, Yen TC.
    Oral Oncol; 2013 Mar 01; 49(3):261-8. PubMed ID: 23036774
    [Abstract] [Full Text] [Related]

  • 20. Prognostic Value of 18F-FDG PET/CT in Surgical Non-Small Cell Lung Cancer: A Meta-Analysis.
    Liu J, Dong M, Sun X, Li W, Xing L, Yu J.
    PLoS One; 2016 Mar 01; 11(1):e0146195. PubMed ID: 26727114
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.